@taracdennehy Oh I am so sorry. How awful to need assistance and not be able to get it. I hope the pressure and pain are a bit better! Fingers crossed for you!
@JaymetheRN@SurgeryBro My mother was sceptical about a DO she was transferred to and I said why don't you see what he's like? ... and he was awesome. So wonderful. And they had a great working relationship.
@kaisu_saloniemi I am so sorry for your loss of the sweetest boy. What sad news. I loved to see Jerry here ... may your memories keep him alive in your heart. ❤️
@JaymetheRN I was involved once in debriefing a group of oncology nurses after a favorite young patient died from his disease. Admin wanted this so much they gave release time to staff and allowed them to go offsite for the meeting. It was incredible. Wish more organizations saw the value.
New Mexico, thank you for believing in what we can build together. I’m honored to officially accept the Democratic nomination for Governor of New Mexico.
Dr. Brian Wolpin @DanaFarber on #daraxonrasib#PancreaticCancer data he presented at #ASCO26:
'I find myself thinking about the large number of patients I have taken care of [and] all of those people who have passed away. ... They deserve this.'
Story 👇
https://t.co/HcDiKn6e0F
The most important paper of #ASCO26 just dropped in Nature Med! Or any other @asco or @myESMO meetings to be honest. When you hear someone present “the toxicities were acceptable”, please respond “downplaying toxicities is not acceptable”. Thank you @NatureMedicine for publishing this piece.
https://t.co/ydAfoTWVJ0
@tmprowell@ScaltritiLab It gives me chills just to watch all these videos in my feed of the same moments and all the applause! Thank you to all who participated and contributed!
Incredible #ASCO26 moment.
Dr. Brian Wolpin, presenter of the daraxonrasib study, received a standing ovation DURING his talk after he stated the survival benefit for PDAC patients. It was sustained. Cheering. I have never see anything like it in the middle of a talk. $RVMD
Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer
Seldom do you sense you’re witnessing a historic moment in cancer care but this feels like ras targeting has arrived
#ASCO26
@marklewismd@DrSarcoma Wow, so amazing. I feel chills up and down my spine. Hope where there was almost none. Thank you so much to all the patients, families, oncologists, researchers, clinical and other staff who made this happen. Progress can be slowed but not stopped. 🙏❤️🦋